IOVS Molecular Pharmacology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2004;45:3330-3336.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0247
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, P. M.
Right arrow Articles by Smith, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, P. M.
Right arrow Articles by Smith, S. B.

Death of Retinal Neurons in Streptozotocin-Induced Diabetic Mice

Pamela M. Martin,1 Penny Roon,1 Tracy K. Van Ells,1 Vadivel Ganapathy,2 and Sylvia B. Smith1,3

1From the Departments of Cellular Biology and Anatomy, 2Biochemistry and Molecular Biology, and 3Ophthalmology, Medical College of Georgia, Augusta, Georgia.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. Neuronal cell death has been reported in retinas of humans with diabetic retinopathy and in diabetic rat models. Little is known about neuronal cell death in mouse models of diabetic retinopathy. This study was designed to determine whether neurons are lost in diabetic mouse retinas and whether the loss involves an apoptotic process.

METHODS. Three-week-old C57Bl/6 mice were made diabetic with streptozotocin. They were studied over the course of 14 weeks after onset of diabetes. Eyes were processed for morphometric analysis and detection of apoptotic cells by TUNEL analysis and activated caspase-3 and were subjected to electron microscopy.

RESULTS. Morphometric analysis of retinal cross sections of mice that had been diabetic 14 weeks showed ~20% to 25% fewer cells in the ganglion cell layer compared with age-matched control mice. There was a modest, but significant, decrease in the thickness of the whole retina and the inner and outer nuclear layers in mice that had been diabetic for 10 weeks. TUNEL analysis and detection of active caspase-3 revealed that cells of the ganglion cell layer were dying by apoptosis. Electron microscopic analysis detected morphologic features characteristic of apoptosis, including margination of chromatin and crenated nuclei of cells in the ganglion cell layer.

CONCLUSIONS. The data suggest that in diabetic mouse retinas, neurons in the ganglion cell layer die, and this death occurs through an apoptotic pathway. Diabetic mice may be appropriate and valuable models for studies of neuronal cell death in diabetes.

The present study examined neuronal cell loss in retinas of diabetic mice. It has become increasingly clear that diabetic retinopathy affects not only retinal vasculature, but also retinal neuronal and glial cells.1 2 3 4 Electrophysiologic studies of human patients with diabetes suggest alterations in the neural retina, such as loss of color and contrast sensitivity, within 2 years of diabetes onset.5 6 Focal ERG analyses, which can detect electrical responses of ganglion cells, reveal dysfunction of these cells early in diabetes.7 8 Analyses of retinal tissue samples from diabetic patients provide further support for the involvement of retinal neurons in diabetic retinopathy. Two studies in the 1960s described loss of retinal neurons in diabetic patients.9 10 Recently, Barber et al.11 analyzed the retinas of diabetic patients by the TUNEL method and observed significantly more apoptotic neurons in retinas of the patients than in control subjects. Similar results were observed by Bek.12 Kerrigan et al.,13 focusing on ganglion cell death in primary open-angle glaucoma, also analyzed eyes of subjects with diabetes (but no glaucoma) and found more TUNEL-positive ganglion cells in these tissues than in retinas of nondiabetic control subjects.

Rodent models have been used to elucidate the mechanisms of retinal cell damage in diabetes. Rats have been used extensively for analysis of vascular and nonvascular alterations. Several groups have established that there are significantly more neuronal cells undergoing apoptosis, particularly in the ganglion cell layer (GCL), in retinas of diabetic rats than in control animals.11 14 15 16 17 Others have observed loss of the axonal fibers in diabetic rat retinas.18 19 20 21 ERG studies performed in diabetic rats have detected reduced ERG responses as early as 2 weeks after onset of diabetes.21 Mice have been used less frequently as models in studies of diabetic retinopathy; however, it is apparent that this species exhibits features of diabetic retinopathy. Vascular changes have been reported in galactose- and streptozotocin (STZ)-induced mouse models of diabetes.22 23 Mohr et al.24 reported increased levels of caspase activation, a marker of apoptosis, in retinas of diabetic mice. In a recent report comparing neuroretinal changes in the rat and mouse, investigators detected ganglion cell death in the rat diabetic model, but not in the mouse model.17 That is, when wholemounted retinas were analyzed for incidence of apoptosis using the TUNEL method, there appeared to be no difference in the number of apoptotic retinal neurons in diabetic mice compared with nondiabetic control mice. To our knowledge, there have been no other studies reported about neuronal cell loss in retinas of diabetic mice. We found this possible species difference in neuronal death between diabetic mice and rats intriguing, especially in light of the report by Kowluru25 in which metabolic changes in retinas of diabetic mice were very similar to those in diabetic rats. Both species showed increased oxidative stress, PKC activity, and nitric oxide (NO) levels in the retina. Given the extraordinary usefulness of mice as models of disease, we sought to explore in detail retinal neuronal cell loss in diabetic mice. In the present study, we systematically analyzed early changes in the mouse retina as a consequence of diabetes, applying several assessments of apoptosis and morphometric analyses. These studies showed that the cells in the retinal GCL of the STZ-induced diabetic mouse undergo apoptosis.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Reagents
Reagents used in these studies were from the following sources: polyclonal antibody against caspase-3 (R&D Systems, Minneapolis, MN); anti-rabbit IgG conjugated to FITC, normal goat serum (Jackson ImmunoResearch, West Grove, PA); goat anti-rabbit IgG conjugated to Cy3 (Molecular Probes, Eugene, OR); antifade mounting medium for fluorescence (Vectashield; Vector Laboratories, Burlingame, CA); optimal cutting temperature (OCT) compound (Tissue Tek; Miles Laboratories, Elkhart, IN); in situ apoptosis detection kit with fluorescein (ApopTAG; Intergen, Purchase, NY); STZ (N-[methylnitrosocarbamoyl]-D-glucosamine) and all other agents (Sigma-Aldrich, St. Louis, MO). The urine strip test was from American Diagnostics (Minneapolis, MN), and the glucometer (Prestige Smart System) was from Home Diagnostics (Woonsocket, RI).

Induction of Experimental Diabetes in Mice
C57BL/6 mice were purchased from Harlan Sprague-Dawley (Indianapolis, IN) and were maintained in our colony, as described previously.26 Diabetes was induced chemically in 3-week-old C57BL/6 mice, according to the method of Phelan et al.27 Mice received an intraperitoneal injection of 75 mg/kg STZ dissolved in sodium citrate buffer (0.01 M, pH 4.5) on three successive days. Mice were screened for diabetes beginning 3 days after the first dose of STZ by testing for the presence of glucose in urine with the urine strip test. At the time of death (2, 4, 6, 8, 10, 12, and 14 weeks after onset of diabetes), the diabetic state of the animal was confirmed by measuring blood glucose levels with a glucometer. Fasting blood glucose levels higher than 250 mg/dL were considered to be diabetic. Insulin was not administered to the animals. Mice were weighed on a weekly basis. Age-matched, nondiabetic C57BL/6 mice were used as the control. Care and use of animals adhered to the institutional guidelines for humane treatment of animals and to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Histologic Processing
Mice were killed by CO2 asphyxiation followed by cervical dislocation. For studies using frozen sections, eyes were enucleated and oriented in OCT so that the 10-µm-thick sections included a full length of retina approximately along the horizontal meridian, passing through the ora serrata and the optic nerve in both the temporal and nasal hemispheres. Eyes were flash frozen, and the cryosections were prepared and mounted on slides (Superfrost; Fisher Scientific, Pittsburgh, PA). They were stained with hematoxylin and eosin and used for morphologic studies. Additional cryosections were used for TUNEL analysis and immunohistochemical studies of active caspase-3. For ultrastructural studies, eyes were enucleated and fixed for 1 hour at room temperature in 2% paraformaldehyde/2% glutaraldehyde in 0.1 M cacodylate buffer in sucrose and postfixed for 1 hour with osmium tetroxide. Processing and embedding of tissue in Epon 812 (EM-bed)-Araldite-502 (Electron Microscopy Sciences, Fort Washington, PA) was performed according to our published protocol.26 For these experiments, 70 mice were used; 42 were diabetic and 28 were age-matched, nondiabetic control mice.

Microscopic Evaluation and Measurement Procedures
Microscopic evaluation of retinas included scanning tissue sections for evidence of gross disease followed by morphometric analysis, which included measurements of the thickness of the total retina, the thickness of the outer nuclear layer, the thickness of the inner nuclear layer, and the number of cells in the GCL. The number of cells in the GCL was quantified by counting cells from the temporal to the nasal ora serrata. Thickness measurements were made in the posterior retina at four points, two on either side of the optic nerve that were approximately 200 to 300 µm apart. These measurements were then averaged to yield a measurement for that particular section. For each animal analyzed, three separate eye sections were measured. All measurements were obtained with a microscope and digital camera (Axioscope; Carl Zeiss, Inc., Oberkochen, Germany; camera equipped with Spot Software ver.4.0.2; Diagnostic Imaging, Sterling Heights, MI).

In Situ Detection of DNA Fragmentation by TUNEL Assay
The TUNEL assay was performed using the in situ apoptosis detection kit with fluorescein, according to our published method.26 Tissues were viewed by epifluorescence by using standard fluorescence excitation and emission filters. Each section was scanned systematically from the temporal to the nasal ora serrata for fluorescent cells indicative of apoptosis. To distinguish between structures that autofluoresced versus those that were TUNEL positive, all slides were examined first with the rhodamine filter and then with the FITC filter. Autofluorescent structures were visible under both filters, whereas TUNEL-positive cells were detectable only with the FITC filter. Positively labeled cells were counted in the GCL.

Immunohistochemical Detection of Active Caspase-3
Immunohistochemical methods were performed on cryosections for the detection of active caspase-3. Cryosections of eyes were fixed in ice-cold acetone for 5 minutes, washed with 0.01 M PBS (pH 7.4) and blocked with 4% normal goat serum for 90 minutes. They were incubated with the primary polyclonal antibody against active caspase-3 (1:250) overnight at 4°C. Negative control sections were treated identically with buffer only or normal rabbit serum. Sections were rinsed and incubated for 1 hour with anti-cy3 antibody (1:500). Tissues were viewed by epifluorescence using standard fluorescence excitation and emission filters. Each section was scanned systematically from the temporal to the nasal ora serrata for fluorescent cells indicative of cells undergoing apoptosis. As in the TUNEL assay, the positive cells were counted.

Image Capture and Data Analysis
Images from the TUNEL assay and immunohistochemical studies of active caspase-3 were obtained with a fluorescence microscope (Axioscope 2; Zeiss) equipped with a digital camera and software (Spot camera and software ver. 4.0.2; Diagnostic Imaging). Analysis of variance was used to determine whether there were significant differences in morphologic measurements and in the number of TUNEL- and caspase-3–positive cells in diabetic versus nondiabetic, age-matched control mice. P < 0.05 was considered significant. Tukey’s paired comparison test was the post hoc statistical test. Measurements obtained in the morphometric analysis of these retinas were analyzed by ANOVA (significance level: P < 0.05, The Tukey post hoc test).


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Three-week-old C57BL/6 mice were made diabetic by injection of 75 mg/kg STZ. Table 1 shows the body weight and blood glucose levels for diabetic and age-matched control mice. Diabetic mice had a 36% gain in weight from 2 to 14 weeks after onset of diabetes, whereas age-matched controls had a 42% gain in weight. By 14 weeks after onset of diabetes, diabetic mice weighed significantly less than control mice. Blood glucose levels differed significantly between diabetic and control mice at all ages studied.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Average Weights and Blood Glucose Levels of Control and Diabetic Mice

 
Morphometric Evaluation of Diabetic Retinas
Before eyes of diabetic mice were subjected to systematic morphometric analysis, the retinas were examined for evidence of gross disease, such as rosettes within the nuclear layers. There was no evidence of gross retinal disease in diabetic mouse retinas up to 14 weeks after onset of diabetes. Systematic morphometric examination of hematoxylin and eosin–stained retinal cryosections showed no significant differences in the total retinal thickness of diabetic mouse retinas compared with nondiabetic, age-matched control retinas at 2, 4, 6, and 8 weeks after onset of diabetes (Fig. 1A) . By 10 to 12 weeks, however, the thickness of retinas of diabetic mice was significantly less than that in age-matched control mice (Fig. 1A) . Specifically, the thickness of the outer and inner nuclear layers was reduced significantly in diabetic mice at 10 to 12 weeks after onset of diabetes (Figs. 1B 1C) . There did not appear to be a significant difference in the thickness of the inner or outer plexiform layers between diabetic and control mice (data not shown).



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 1. Morphometric analysis of diabetic and age-matched, nondiabetic control mouse retina. Hematoxylin and eosin-stained cryosections of retinas from diabetic and age-matched control retinas were subjected to morphometric analysis at 2, 4, 6, 8, 10, and 12 weeks after onset of diabetes. (A) Total retinal thickness. (B) Thickness of the outer nuclear layer (ONL). (C) Thickness of the inner nuclear layer (INL). Data are the means ± SE of measurements in retinas of four control and six diabetic mice. *Significantly different from control (P < 0.05).

 
Additional measurements were made of the number of cells in the GCL of diabetic and control mice. A hematoxylin and eosin–stained section of the retina of a control mouse age matched to a mouse that had been diabetic for 12 weeks is shown in Figure 2 . Retinas of control mice had a GCL in which the cells were densely packed. There was typically a uniform distribution of cells. Except for occasional blood vessels, there was little space intervening between cells. In contrast, diabetic retinas demonstrated a loss of cells in the GCL. There were areas where the distribution of ganglion cells appeared normal adjacent to areas devoid of any cells. The arrow in Figure 2B indicates a region of cellular dropout.



View larger version (40K):
[in this window]
[in a new window]
  		FIGURE 2. Light microscopic evaluation of diabetic and age-matched, nondiabetic control retina. Hematoxylin and eosin–stained cryosections of retinas of control (A) and diabetic (B) mice (12 weeks after onset of diabetes). The cells of the GCL are uniformly distributed in the control mouse, whereas there are areas of cellular dropout (arrow) in the diabetic retina. gcl, ganglion cell layer; inl, inner nuclear layer; onl, outer nuclear layer; rpe, retinal pigment epithelium.

 
To determine whether there is a significant difference in the number of cells in the GCL of diabetic versus control mice, the cells were counted in sections of eyes from the temporal to the nasal ora serrata. As shown in Figure 3 , control retinas typically had ~500 to 550 cells in cross sections of this layer throughout all ages studied. During the first few weeks of diabetes, the number of cells in the GCL did not differ significantly from control animals. However, by 10 to 14 weeks after onset of diabetes, there were significantly fewer (~20%–25%) cells in the GCL in diabetic retinas compared with control retinas (P < 0.05). When data were expressed as number of cells per 100-µm length of retina, there were significantly fewer cells in 10-week diabetic mice (10.31 ± 0.5 cells/100 µm retinal length) than in age-matched, nondiabetic mice (15.8 ± 0.6 cells/100 µm retinal length).



View larger version (36K):
[in this window]
[in a new window]
  		FIGURE 3. Number of cells in the GCL of diabetic and control mouse retinas. The GCL was analyzed in hematoxylin and eosin–stained cryosections of retinas of diabetic and age-matched control mice at 2 to 14 weeks after onset of diabetes. *Significantly different from the control (P < 0.01). Error bars, SE.

 
TUNEL Analysis and Detection of Active Caspase-3
To characterize the cell loss observed in the GCL of diabetic mice, we applied two assays of cell death, the TUNEL assay and detection of active caspase-3. TUNEL analysis detects cells in which DNA is fragmenting and, though used widely as a marker for apoptosis, also reflects cells dying by necrosis.28 Active caspase-3 is a marker of apoptosis.29 Examination of retinas of diabetic mice showed many TUNEL- and caspase-3–positive cells in the GCL, whereas control mice had few positive cells. Photomicrographs of retinas processed for the TUNEL assay and detection of active caspase-3 are shown in Figure 4 . Cryosections of eyes from mice killed 2, 6, and 12 weeks after onset of diabetes and age-matched control sections were analyzed to determine the number of TUNEL and active caspase-3–positive cells. In the results of both assays, there were significantly more positive cells in the GCL of retinas of diabetic mice than in control mice. Data for the analysis of caspase-3 are shown in Figure 5 . Of note, the presence of TUNEL-positive and active caspase-3–positive cells was not limited to the GCL. The inner nuclear layer demonstrated occasional positive cells, as did the outer nuclear layer of photoreceptor cell nuclei, at all ages studied (data not shown).



View larger version (38K):
[in this window]
[in a new window]
  		FIGURE 4. Fluorescence microscopic detection of TUNEL-positive and caspase-3–positive neurons in retinas of diabetic and control mice. TUNEL analysis of retinas of (A) control and (B) diabetic mice 6 weeks after onset of diabetes. Bright fluorescent signal (arrows) indicates TUNEL-positive cells. Detection of active caspase-3 in retinas of (C) control mice and (D) diabetic mice. Blue fluorescent signal: nuclei of all cells stained with 4',6'-diamino-2-phenylindole (DAPI); red signal: cells positive for caspase-3 (arrows). Magnification, x400.

 


View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 5. Number of caspase-3–positive neurons of the GCL in diabetic and age-matched, nondiabetic control mouse retinas. Cells in the GCL of retinal sections that were positive for active caspase-3 were counted from the temporal to nasal ora serrata in control and diabetic mice at 2, 6, and 12 weeks after onset of diabetes. *Significantly different from age-matched, nondiabetic control (ANOVA P < 0.01, post hoc test was significant at P < 0.05 for 2 weeks and at P < 0.01 for 6 and 12 weeks). Error bars, SE.

 
Electron Microscopic Analysis of Diabetic Retinas
Retinal sections were examined systematically to determine whether the neurons of the GCL exhibit ultrastructural features characteristic of apoptotic cell death. Figure 6 shows light micrographs of toluidine blue–stained, Epon-embedded retinal sections of control and diabetic eyes (4 weeks after onset of diabetes). In control retinas, the cells of the GCL were uniform in size and distribution (Fig 6A) . The toluidine blue staining of the cells was a pale, mottled blue. Blood vessels were unremarkable in control eyes. The toluidine blue–stained sections of a retina of a diabetic mouse 4 weeks after onset of diabetes showed an increased number of darker-staining (deep purple), shrunken cells reminiscent of dying cells (Fig. 6B) . The blood vessels were much more noticeable in the diabetic retina and appeared as small tufts emerging through the GCL and projecting into the nerve fiber layer. Dark, shrunken cells in the GCL and small vascular tufts were observed in 12 of 12 eyes of mice that were examined at 4 weeks after onset of diabetes. Ultrastructural analysis of the shrunken cells in the GCL revealed the classic morphologic characteristics of apoptosis (including margination of chromatin and crenated nuclei; Fig. 6C ). As is typical of apoptosis, adjacent cells within the same layer appeared normal (Fig. 6D) . Cells of the GCL in control mice had uniformly normal-appearing nuclei when examined at the ultrastructural level (data not shown). Ultrastructural examination of other cell types in the diabetic retinas revealed occasional evidence of apoptosis, particularly in the inner nuclear layer (data not shown).



View larger version (102K):
[in this window]
[in a new window]
  		FIGURE 6. Ultrastructural analysis of diabetic mouse retina. Light photomicrographs of toluidine blue–stained Epon-embedded retinal sections of control (A) and diabetic mice (4 weeks after onset of diabetes; B). Arrows: deeply stained, shrunken cells; arrowhead: a vascular tuft emerging through the GCL into the nerve fiber layer. Electron micrograph of cells in the GCL of diabetic mouse retina that were deeply stained and shrunken (C) adjacent to cells within the same retina that were normal in appearance (D). Magnification: (A, B) x400; (C, D) x7700.

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
In the present study, we examined neuronal cell death in retinas of diabetic mice. Two important findings emerged from this work. The first is that diabetic mice demonstrated a significant loss of cells in the GCL during diabetes. Retinas of diabetic and age-matched control mice were analyzed morphometrically by measuring the thickness of various retinal layers and by counting the number of neurons in the GCL. Initially, the thickness of the inner and outer nuclear layers did not differ significantly between diabetic and nondiabetic mice. By 10 weeks after onset of diabetes, however, both inner and outer nuclear layers were significantly thinner in retinas of diabetic compared with control mice. In studies of rat models of diabetes, Barber et al.11 reported significant differences in the thickness of the inner nuclear layer as a consequence of diabetes. Park et al.30 reported thinning of the inner nuclear layer and marked thinning of the outer nuclear layer by 24 weeks after onset of diabetes. Similar to the study by Barber et al.11 was our finding that the number of neurons in the GCL decreased significantly in retinas of diabetic mice as the diabetes progressed compared with age-matched control mice. Our data presenting the number of neurons in retinal cross sections (Fig. 3) provide strong evidence that neurons are lost in the GCL of diabetic mice. Our observation that the inner and outer nuclear layers were thinner in diabetic mice suggests neuronal cell loss in these layers as well.

The second important finding was that neurons of the GCL in diabetic mice were dying by apoptosis. This conclusion is based on several assays for apoptosis. In our study, we used 10-µm-thick frozen sections for the TUNEL assay and detection of active caspase-3. In addition, we embedded retinas in Epon for study by electron microscopy, as apoptosis is classically defined by its morphologic features.31 In both preparations (frozen and plastic-embedded sections), it was clear that cells of the GCL were affected. TUNEL assays and assays to detect caspase-3, both markers of apoptosis, showed significantly more positive cells in this layer in diabetic mouse retinas than in age-matched control retinas. In addition, electron microscopic studies revealed cells in the GCL that had the classical morphologic characteristics of apoptosis, whereas such features were rarely observed in nondiabetic control retinas. A recent paper, Asnaghi et al.17 examined TUNEL-positive cells in diabetic rat retinas and found a fourfold increase in the number of apoptotic neurons. They also examined diabetic mouse retinas and concluded that neural apoptosis was not a feature of the diabetic mouse retina. In that report, wholemounted retinas (rather than retinal cross sections) were subjected to TUNEL assay and examined by fluorescence. The TUNEL-positive cell count data were presented, and analysis of four retinas at 10 weeks’ duration of diabetes and five retinas at 24 weeks’ duration revealed no difference in TUNEL-positive cells. Our data (Fig. 4B) from TUNEL analysis of representative sections of mouse retina (6 weeks diabetic) showed several TUNEL-positive cells in the GCL. One significant difference between the two studies was that we did not maintain our mice on insulin, whereas Asnaghi et al. used a low dosage of insulin to prevent weight loss. No data about the number of neurons in the retinas of diabetic mice were provided; thus, we cannot compare this aspect of our study with that of Asnaghi et al.

The data obtained from these studies suggest that mice are a valid model for studies of neuronal cell death in diabetic retinopathy, consistent with findings in other species. The work is not merely an extension of an observation to an additional species, however, because of the profound usefulness of mice in experimental biology. There are many transgenic and knockout mouse strains available in which specific genes are nonfunctional. Using strains in which the nonfunctional gene encodes a protein thought to play a role in the complications of diabetes, one can induce diabetes and test whether the combined effects of the lack of gene function coupled with diabetes accelerates, delays, worsens, or prevents the retinal diabetic phenotype. Mouse retinas could be examined for vascular changes, described by others, as well as neuronal changes observed in the present study. An effort to characterize retinal phenotypes in various mutant mouse strains, which have been made diabetic, has gotten under way recently through the Animal Models of Diabetic Complications Consortium (http://www.amdcc.org).

In the present work, we did not attempt to determine the cause of neuronal cell death in the diabetic mouse retina. Recent reports of elevation of glutamate in the vitreous of humans with diabetes32 and in rat models33 34 would justify investigations of the role of this excitatory amino acid in the neuronal cell death observed in diabetic mice. Observations from our laboratory that the intravitreal injection of excitatory amino acid homocysteine leads to death of cells in the GCL26 may suggest another possible mechanism of cell death in diabetic retinopathy, given the possible association of elevated levels of homocysteine in diabetes and diabetic retinopathy.35 36 37 The potential role of increased oxidative stress, PKC activity, and nitric oxide (NO) levels in the retina would be other logical areas to investigate as mediators of neuronal cell death in diabetic mouse retinas.25 38 39 The abundance of mouse models having mutations in relevant genes will permit elegant studies of the interaction of diabetes with other genes in the development of neuronal cell death in diabetic mice.


   Footnotes
 
Supported by National Eye Institute Grants EY14560 and EY13089.

Submitted for publication March 3, 2004; revised April 22, 2004; accepted May 10, 2004.

Disclosure: P.M. Martin, None; P. Roon, None; T.K. Van Ells, None; V. Ganapathy, None; S.B. Smith, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Sylvia B. Smith, Medical College of Georgia, Department of Cellular Biology and Anatomy, CB 2820, Augusta, GA 30912-2000; sbsmith{at}mail.mcg.edu.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2000;28:3–8.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  2. Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia. 2001;44:791–804.
  3. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47:S253–S262.
  4. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283–290.[CrossRef][Medline][Order article via Infotrieve]
  5. Roy M, Gunkel R, Podgor M. Color vision defects in early diabetic retinopathy. Arch Ophthalmol. 1986;104:225–228.[Abstract/Free Full Text]
  6. Hirsh J, Puklin J. Reduced contrast sensitivity may precede clinically observable retinopathy in type 1 diabetes. Henkind P eds. Acta XXIV International Congress of Ophthalmology. 1982;719–724. JB Lippincott New York.
  7. Greco AV, Di Leo MA, Caputo S, et al. Early selective neuroretinal disorder in prepubertal type 1 (insulin-dependent) diabetic children without microvascular abnormalities. Acta Diabetol. 1994;31:98–102.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  8. Ghirlanda G, Di Leo MA, Caputo S, et al. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes. 1991;40:1122–1127.[Abstract]
  9. Wolter JR. Diabetic retinopathy. Am J Ophthalmol. 1961;51:1123–1139.[Web of Science][Medline][Order article via Infotrieve]
  10. Bloodworth JMB. Diabetic retinopathy. Diabetes. 1962;2:1–22.
  11. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102:783–791.[Web of Science][Medline][Order article via Infotrieve]
  12. Bek T. Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol (Copenh). 1994;72:409–415.
  13. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997;115:1031–1035.[Abstract/Free Full Text]
  14. Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med. 1997;1:527–534.
  15. Sima AA, Zhang WX, Cherian PV, Chakrabarti S. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia. 1992;35:602–607.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  16. Kim YS, Kim YH, Cheon EW, et al. Retinal expression of clusterin in the streptozotocin-induced diabetic rat. Brain Res. 2003;976:53–59.[Medline][Order article via Infotrieve]
  17. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;52:506–511.[Abstract/Free Full Text]
  18. Zhang L, Inoue M, Dong K, Yamamoto M. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res. 2000;20:131–136.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  19. Scott TM, Foote J, Peat B, Galway G. Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. J Anat. 1986;144:145–152.[Medline][Order article via Infotrieve]
  20. Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology. 1993;100:1147–1151.[Web of Science][Medline][Order article via Infotrieve]
  21. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res. 2002;74:615–625.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  22. Kern TS, Engerman RL. A mouse model of diabetic retinopathy. Arch Ophthalmol. 1996;114:986–990.[Abstract/Free Full Text]
  23. Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002;51:3107–3112.[Abstract/Free Full Text]
  24. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51:1172–1179.[Abstract/Free Full Text]
  25. Kowluru RA. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res. 2002;24:123–128.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  26. Moore P, El-Sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB. Apoptotic retinal ganglion cell death is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73:45–57.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  27. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes. 1997;46:1189–1197.[Abstract]
  28. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995;7:61–64.[Web of Science][Medline][Order article via Infotrieve]
  29. Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta. 2002;326:27–45.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  30. Park SH, Park JW, Park SJ, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003;46:1260–1268.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  31. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.[Web of Science][Medline][Order article via Infotrieve]
  32. Ambati J, Chalam KV, Chawla DK, et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997;115:1161–1166.[Abstract/Free Full Text]
  33. Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes. 1998;47:815–820.[Abstract]
  34. Kowluru RA, Engerman RL, Case GL, Kern TS. Retinal glutamate indiabetes and effect of antioxidants. Neurochem Int. 2001;38:385–390.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  35. Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocystenemia and endothelial dysfunction in IDDM. Diabetes Care. 1998;21:841–848.[Abstract]
  36. Hultberg B, Agardh CD, Agardh E, Lovestam-Adrain M. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. J Clin Lab Invest. 1997;57:595–600.[Web of Science][Medline][Order article via Infotrieve]
  37. Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet. 1997;349:473–474.[Web of Science][Medline][Order article via Infotrieve]
  38. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol. 2002;47(suppl 2)S263–S269.
  39. Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol. 2002;133:693–698.[CrossRef][Web of Science][Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 IOVSHome page
H. W. van Dijk, P. H. B. Kok, M. Garvin, M. Sonka, J. H. DeVries, R. P. J. Michels, M. E. J. van Velthoven, R. O. Schlingemann, F. D. Verbraak, and M. D. Abramoff
Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3404 - 3409.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. A. Berkowitz, M. Gradianu, D. Bissig, T. S. Kern, and R. Roberts
Retinal Ion Regulation in a Mouse Model of Diabetic Retinopathy: Natural History and the Effect of Cu/Zn Superoxide Dismutase Overexpression
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2351 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
P. E. Fort, W. M. Freeman, M. K. Losiewicz, R. S. J. Singh, and T. W. Gardner
The Retinal Proteome in Experimental Diabetic Retinopathy: Up-regulation of Crystallins and Reversal by Systemic and Periocular Insulin
Mol. Cell. Proteomics, April 1, 2009; 8(4): 767 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Parravano, F Oddone, D Mineo, M Centofanti, P Borboni, R Lauro, L Tanga, and G Manni
The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes
Br. J. Ophthalmol., December 1, 2008; 92(12): 1656 - 1660.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
T. S. Kern and A. J. Barber
Retinal ganglion cells in diabetes
J. Physiol., September 15, 2008; 586(18): 4401 - 4408.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. B. Smith, J. Duplantier, Y. Dun, B. Mysona, P. Roon, P. M. Martin, and V. Ganapathy
In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4154 - 4161.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Kohzaki, A. J. Vingrys, and B. V. Bui
Early Inner Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3595 - 3604.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. G. Field, V. M. Elner, D. G. Puro, J. M. Feuerman, D. C. Musch, R. Pop-Busui, R. Hackel, J. R. Heckenlively, and H. R. Petty
Rapid, Noninvasive Detection of Diabetes-Induced Retinal Metabolic Stress
Arch Ophthalmol, July 1, 2008; 126(7): 934 - 938.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber
Dendrite Remodeling and Other Abnormalities in the Retinal Ganglion Cells of Ins2Akita Diabetic Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2635 - 2642.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Kusari, S. Zhou, E. Padillo, K. G. Clarke, and D. W. Gil
Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5152 - 5159.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
C. Biallosterski, M. E J van Velthoven, R. P J Michels, R. O Schlingemann, J H. DeVries, and F. D Verbraak
Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy
Br. J. Ophthalmol., September 1, 2007; 91(9): 1135 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. A. Gardiner, and A. W. Stitt
Retinopathy Is Reduced during Experimental Diabetes in a Mouse Model of Outer Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5561 - 5568.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Jiang, B. Mysona, Y. Dun, J. P. Gnana-Prakasam, N. Pabla, W. Li, Z. Dong, V. Ganapathy, and S. B. Smith
Expression, Subcellular Localization, and Regulation of Sigma Receptor in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5576 - 5582.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. E. van Eeden, L. B. G. Tee, S. Lukehurst, C.-M. Lai, E. P. Rakoczy, L. D. Beazley, and S. A. Dunlop
Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4638 - 4645.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al.
Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Diabetes, September 1, 2006; 55(9): 2401 - 2411.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Vujosevic, E. Midena, E. Pilotto, P. P. Radin, L. Chiesa, and F. Cavarzeran
Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3044 - 3051.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Gastinger, R. S. J. Singh, and A. J. Barber
Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3143 - 3150.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Am. J. Pathol., January 1, 2006; 168(1): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T. S. Kern, and D. F. Chen
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4281 - 4287.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. K.H. Cheung, M. K.L. Fung, A. C.Y. Lo, T. T.L. Lam, K. F. So, S. S.M. Chung, and S. K. Chung
Aldose Reductase Deficiency Prevents Diabetes-Induced Blood-Retinal Barrier Breakdown, Apoptosis, and Glial Reactivation in the Retina of db/db Mice
Diabetes, November 1, 2005; 54(11): 3119 - 3125.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson
The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, P. M.
Right arrow Articles by Smith, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, P. M.
Right arrow Articles by Smith, S. B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS